For privately held biotechs, IPOs are the most common road to the public markets, but they're not the only way. Reverse merging with a shell company ...
Growth Capitalist (https://growthcapitalist.com/2016/11/with-reverse-merger-miragen-to-go-public-get-40m-boost-from-investors/)
For privately held biotechs, IPOs are the most common road to the public markets, but they're not the only way. Reverse merging with a shell company ...